Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: A primary role for tyrosine phosphatase SHP-1

Endocrinology

Volumn 140, Issue 2, 1999, Pages 765-777

  Douziech, Nadine ^a   Calvo, Ezéquiel ^a   Coulombe, Zoé ^a   Muradia, Gauri ^b   Bastien, Jacinthe ^c   Aubin, Rémy A ^b,c   Lajas, Ana ^d   Morisset, Jean ^a,e  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b HEALTH CANADA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF EXTREMADURA   (Spain)

^e Groupe en Sciences des Radiations   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; SOMATOSTATIN;

ARTICLE; CELL PROLIFERATION; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; EXOCRINE SECRETION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032934791     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.2.6492     Document Type: Article

References (51)

1. 1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R 1973 Hypothalamic polypeptide that inhibits secretion of immuno-reactive pituitary growth hormone. Science 179:77-79
2. 2. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495-1501
3. 3. Boden G, Sivitz MC, Owen OE 1975 Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 190:163-165
4. 4. Schally AV, Coy DH, Meyers CA 1978 Hypotalamic regulatory hormones. Annu Rev Biochem 47:89-128
5. 5. Liebow C, Hierowski M, DuSapin K 1986 Hormonal control of pancreatic cancer growth. Pancreas 1:44-48
6. 6. Viguerie N, Tahiri-Jouti N, Ayral AM, Cambillau C, Scemama JL, Bastie MJ, Knuhtsen S, Esteve JP, Pradayrol L, Susini C, Vaysse N 1989 Direct inhibitory effects of a somatostatin analogue, SMS 201-995, on AR4-2J cell proliferation via a pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology 24:1017-1025
7. 7. Bell GI, Reisine T 1993 Molecular biology of somatostatin receptors. Trends Neurosci 16:34-38
8. 8. Lewin MJ 1992 The somatostatin receptor in the GI tract. Annu Rev Physiol 54:455-468
9. 9. Liebow C, Reilly C, Serrano M, Schally AV 1989 Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86:2003-2007
10. 10. Pan MG, Florio T, Stork PJS 1992 G protein activation of a hormone-stimu-lated phosphatase in human tumor cells. Science 256:1215-1217
11. 11. Colas B, Cambillau C, Buscail L, Zeggari M, Esteve JP, Lautre V, Thomas F, Vaysse N, Susini C 1992 Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem 207:1017-1024
12. 12. Hierowski MT, Liebow C, Du Sapin K, Schally AV 1985 Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line. FEBS Lett 179:252-256
13. 13. Zeggari M, Esteve JP, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle JA, Vaysse N, Susini C 1994 Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J 303:441-448
14. 14. Lopez F, Esteve JP, Buscail L, Delesque N, Saint-Laurent N, Theveniau M, Nahmias C, Vaysse N, Susini C 1997 The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signalling. J Biol Chem 272:24448-24454
15. 15. Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N, Susini C 1995 Inhibition of cell proliferation by somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 92:1580-1584
16. 16. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C, Buscail L 1997 Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA 94:9343-9348
17. 17. Cattaneo MG, Amoroso D, Sanguini AM, Vicentini LM 1996 A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinuma cell lines. FEBS Lett 397:164-168
18. 18 Yoshitomi H, Fujii Y, Miyazakim NN, Inagaki N, Seino S 1997 Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin. Am J Physiol 272:E769-E774
19. 19. Todisco A, Seva C, Takeuchi Y, Dickinson CJ, Yamada T 1995 Somatostatin inhibits AP-1 function via multiple protein phosphatase. Am J Physiol 269:G160-G166
20. 20. Schally AV 1988 Oncological applications of somatostatin analogues. Cancer Res 48:6977-6985
21. 21. Upp JR, Olson GJ, Alexander RW, Townsend CM, Thompson JC 1988 Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analogue SMS 201-995. Am J Surg 155:29-35
22. 22. Tahiri-Jouti N, Cambillau C, Viguerie N, Vidal C, Buscail L, Saint-Laurent N, Vaysse N, Susini C 1992 Characterization of a membrane tyrosine phosphatase in AR4-2J cells: regulation by somatostatin. Am J Physiol 262:G1007-G1014
23. 23. Lierh RH, Melnykovych G, Solomon TE 1990 Growth effects of regulatory peptides on human pancreatic cancer cell lines MIA PaCa-2 and PANC-1. Gastroenterology 98:1666-1674
24. 24. Gillespie J, Poston GJ, Schachter M, Guillou PJ 1992 Human pancreatic cancer cell lines do not express receptor for somatostatin. Br J Cancer 66:483-487
25. 25. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
26. 26. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Liuis F, Vaysse N, Ssini C 1996 Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56:1823-1827
27. 27. Kameshita I, Fujisawa H 1989 A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem 183:139-143
28. 28. MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA 1990 Cyanobacterial microcystin LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett 264:187-192
29. 29. Fisher WE, Doran TA, Muscarella IP, Boros LG, Ellison EC, Schrimer WJ 1998 Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst 90:322-324
30. 30. Korc M, Magun BE 1985 Binding and processing of epidermal growth factor in PANC-1 human pancreatic carcinoma cells. Life Sci 36:1849-1855.
31. 31. Rivard N, Rydzewska G, Lods JS, Morisset J 1995 Novel model of integration of signaling pathways in rat pancreatic acinar cells. Am J Physiol 269:G352-G362
32. 32. Duan RD, Williams JA 1994 Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol 267:G401-G408
33. 33. Douziech N, Calvo E, Lainé J, Morisset J 1998 Activation of ERK-2 and p38 MAP kinase in growth responsive pancreatic cancer cells: presence of a constitutive ERK-1 activity. Gastroenterology 114:A454 (Abstract)
34. 34. Seger R, Krebs EG 1995 The MAPK signaling cascade. FASEB J 9:726-735
35. 35. Morisset J 1984 Somatostatin: a potential antigrowth factor for the exocrine pancreas. Regul Pept 10:11-22
36. 36. Bousquet C, Delesque N, Lopez F, Saint-Laurent N, Estève N, Bedecs K, Buscail L, Vaysse N, Susini C 1998 sst2 Somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem 273:7099-7106
37. 37. Neel BG, Tonks NK 1997 Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 9:193-204
38. 38. Smith JJ, Derynck R, Korc M 1987 Production of transforming growth factor α in human pancreatic cancer cells: evidence for superagonist autocrine cycle. Proc Natl Acad Sci USA 84:7567-7570
39. 39. Ishizuka J, Beauchamp RD, Evers BM, Townsend CM, Thompson JC 1992 Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells. Biochem Biophys Res Commun 185:577-581
40. 40. Kamiya Y, Ohmura E, Arai M, Fujii T, Hayakawa F, Ito J, Kawaguchi M, Tsushima T, Sakuma N 1993 Effect of somatostatin ans its analogue on proliferation of human epidermoid carcinoma cells in vitro. Biochem Biophys Res Commun 191:302-307
41. 41 Kamiya Y, Ito J, Fujii T, Horie K, Kawaguchi M, Hori R, Fujinami S, Fujinami T 1995 In vitro and in vivo effects of somatostatin on the growth of A431 cells. Horm Metab Res 27:179-181
42. 42 Koper JW, Markstein R, Kohler DJ, Kwekkeboom CJJ, Lamberts SWJ, Reubi JC 1992 Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74:543-547
43. 43. Cardoso A, Ghamrawy CE, Gautron JP, Horvat B, Gautier N, Enjalbert A, Krantic S 1998 Somatostatin increases mitogen-induced IL-2 secretion and proliferation oh human Jurkat T cells via sst3 receptor isotype. J Cell Biochem 68:62-73
44. 44. Sgambati SA, Zarif A, Basson MD 1996 Octreotide differentially modulates human Caco-2 intestinal epithelial cell proliferation and differentiation by decreasing intracellular cAMP. Regul Pept 61:219-227
45. 45. Rivard N, McKenzie FR, Brondello JM, Pouyssegur J 1995 The phosphotyrosine phosphatase PTP1D but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G-protein coupled receptors. J Biol Chem 270:11017-11024
46. 46. Milarski RL, Sartiel AR 1994 Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 269:21239-21244
47. 47 Xiao S, Rose W, Sasaoka T, Maegawa H, Burke TR., Roller PP, Shoelson SE, Olefsky JM 1994 Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 269:21244-21248
48. 48. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell MJ 1997 T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J Biol Chem 272:15023-15027
49. 49. Cohen PS, Schmidtmayerova H, Dennis J, Dubrovsky L, Sherry B, Wang H, Bukrinsky M, Tracey KJ 1997 The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med 3:339-346
50. 50. Dieckgraefe BK, Weems DM, Santoro SA, Alpers DH 1997 ERK and p38 MAP kinase pathways are mediators of intestinal wound-induced signal transduction. Biochem Biophys Res Commun 233:389-394
51. 51. Schafer C, Dabrowski A, Williams JA 1997 p38 MAP kinase is activated by cholecystokinin in pancreatic acinar cells. Gastroenterology 112:A478